


ABOUT US
ABOUT US


Who we are
Cytora LTD, is a Cell Therapy Company that commenced operations in 2018.
Cytora has discovered a novel stem cell population derived from the readily accessible oral mucosa termed human oral mucosa stem cells - hOMSC.
Cytora has developed a revolutionary technology to produce “off the shelf” (allogeneic) therapeutic doses of hOMSC to treat some of the most challenging diseases of this decade including chronic wounds such as incurable diabetic foot ulcers (IDFU) and degenerative diseases such as Parkinson's Disease, Multiple System Atrophy (MSA), and Alzheimer’s Disease.

Our new facility




Total of 500sqm (offices, labs and clean room).
​​
60sqm cGMP manufacturing facility, including in-house cell bank storage in liquid nitrogen and warehouse​.
Cytora's manufacturing facility is Grade B compliant and includes all the equipment for cell therapy manufacturing process.
​​
Cytora's labs are equipped with Real Time PCR, ELISA, fluorescence microscope and other state-of-the-art lab equipment for R&D and QC purposes.

Our Mission
Cytora is on a mission to make it standard practice for people to be treated with off-the-shelf Stem Cell medicines for some of the most challenging diseases within this decade.
Our Vision
Our vision is to improve and save the lives of millions of patients worldwide through our unique patented stem cell platform technology, making it accessible and affordable.